About: Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 22 December 2014

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 2014 (uk) article scientifique publié en 2014 (fr) scientific article published on 22 December 2014 (en) artículu científicu espublizáu n'avientu de 2014 (ast)
publication date	wds:Q86403207-46AB2819-EEF7-4613-A970-39EBADC4BD3B
publication date	2014-12-22 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q86403207-A266711B-D039-4CA7-A6B2-DEE01C3D808E
language of work or name	English
cites work	wds:Q86403207-077C498D-1BEE-4C59-912F-0162F3AF362E wds:Q86403207-07FFCCD3-FCD2-4B71-94BC-238FF4E04139 wds:Q86403207-0E5A3B47-D0D0-47B0-822D-CCBDB4FA9F26 wds:Q86403207-1BEEEF3B-374B-4377-B164-6C63DB8A1059 wds:Q86403207-220BCBAF-68FC-4CA2-A3A4-70DC485E2087 wds:Q86403207-2342A545-7DEB-4BE3-83C3-64FA8EC30CC6 wds:Q86403207-26668A5B-83E0-488D-BDE8-19AFAC1D0A0F wds:Q86403207-2D84CA66-6225-4A66-914B-3FD8163998E4 wds:Q86403207-50B822EC-4B5E-4419-9A15-B5F60676BD44 wds:Q86403207-56EB7D30-D387-4317-96BD-EEE7F7A64AB4 wds:Q86403207-5D8AE247-7FBF-41F6-B480-8C903F9EC272 wds:Q86403207-66660307-50BE-4CFE-9ACB-4901F10B32C0 wds:Q86403207-72B7E5C4-4EE1-4E09-BA09-81B168AE2A10 wds:Q86403207-84E8E295-5C29-4BCB-8FA6-1C17F352B619 wds:Q86403207-943F128E-69B8-41B7-874F-C094CEC520FF wds:Q86403207-96C785C6-A6DF-40A9-99A7-0873AE68B50E wds:Q86403207-B2B5E23C-C7CD-481C-A2D7-561ABBA49833 wds:Q86403207-BD2FE960-7536-493D-ADEB-E949A690B726 wds:Q86403207-CC524CA1-E66D-48B2-ADC8-F689340B4663 wds:Q86403207-CEA424E0-34FE-4777-861D-99C26D42EFA0 wds:Q86403207-DA704CCC-EFDF-4C3F-B455-B736B3E1E804 wds:Q86403207-EEF157BD-3700-4BCA-BEFB-1D5ED9968A84 wds:Q86403207-EF225C67-45FA-4B9E-B04A-78C64F27699C
cites work	Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3,888 patients. International Hodgkin's Disease Collaborative Group. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease. ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen? FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease--a useful tool for monitoring pulmonary toxicity and disease activity. Results of a randomized study of early stage Hodgkin's disease using ABVD, EBVD, or MBVD Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomize Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma A randomized trial of brief treatment of early- stage Hodgkin lymphoma: Is it effective?
author name string	wds:Q86403207-008247D2-D03D-48E7-81F9-F0DA1450F7E4 wds:Q86403207-0FB7412A-1EAE-48A4-8360-43236346760B wds:Q86403207-1D7D1D40-D0EF-4581-AF1F-357F4D87B3F1 wds:Q86403207-37AD2623-9481-449D-AAD1-126AEA3F01A7 wds:Q86403207-39E9404F-5BEA-4AC4-B83D-0E61A066D021 wds:Q86403207-48726423-300E-41D4-9328-C1F26892386F wds:Q86403207-4AB114BA-EFBD-462D-B6C1-4DFBB8CCF171 wds:Q86403207-4D06EE8A-8CED-4C81-899C-B0046EAAFEFF wds:Q86403207-4EF83F1C-BE69-45DF-8406-8C91076042C6 wds:Q86403207-5AD5F894-46CE-4763-8786-90580F3074AE wds:Q86403207-5AFB5916-ACC5-4B0B-9C75-91A7F0E8D4FD wds:Q86403207-65E2A94E-D130-4D55-9893-4053811DA6FC wds:Q86403207-6E7F33B7-7144-4FC1-9FF3-F9F9E506CA61 wds:Q86403207-835186C1-C595-4C4B-8E18-9692F32423BF wds:Q86403207-83C36E86-4DE6-4FE0-A755-61F6BAED1449 wds:Q86403207-8B1303BC-2CD1-4D58-946D-F07A0B614A5A wds:Q86403207-8D700134-6ED3-4420-B514-E34A3F6A91A2 wds:Q86403207-99128A89-1943-455B-8553-896FB37C0B79 wds:Q86403207-9B90B9B5-EB40-40D5-9BE6-896B716A1367 wds:Q86403207-A9448B0E-4489-42E7-8DB3-C992437F4715 wds:Q86403207-B124B94C-1366-42BF-8A63-11D0028AF929 wds:Q86403207-B6A94ED8-6520-49A5-9BFE-9EB5064743A0 wds:Q86403207-BB22EEF5-3795-4528-8D04-D8596A3A4F0A wds:Q86403207-BB9BD650-FA4B-4CC3-8860-A3632CA114AB wds:Q86403207-BD7A095F-52EF-489D-BD76-2887E6EDE6FC wds:Q86403207-C35F4801-C07D-4913-994D-8989F22398EB wds:Q86403207-D2C6E46D-5CC6-4CF9-948C-0A9604E5D448 wds:Q86403207-D389AD31-D01B-4E95-8BA7-7EB86FD13CA2 wds:Q86403207-DD2723B1-D7A7-408B-B34D-81FA13C79401 wds:Q86403207-E0A7ED97-E969-4796-A8C0-67B0C0DC9F4D wds:Q86403207-E1FBFD75-A1EB-4835-B063-FE15928A3249 wds:Q86403207-E3ECC5DF-D30B-4098-BA5E-27B91FFA3DCA wds:Q86403207-F164609F-1EE7-4BA6-93CB-4D59579020AB wds:Q86403207-F4B7BCE9-0C26-47DE-8959-7CBDAD82B168 wds:Q86403207-F797B5EC-09F5-404C-9C9B-3E98A36B629A wds:Q86403207-FDA5AF2F-E3A5-4C45-B88C-836B16C94A09 wds:Q86403207-FFFC36A6-1EB8-4327-BB23-C5A11461874A
author name string	Andreas Engert Bastian von Tresckow Nicole Skoetz Michael Hallek Michael Fuchs Peter Koch Harald Stein

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software